Sinopharm Capital Investments has established a life sciences company.

According to the Qichacha APP, recently, Xintai Life Science (Shenzhen) Co., Ltd. was established with a registered capital of 22 million RMB. Its business scope includes the development of human genetic diagnosis and treatment technology. Equity penetration displayed on Qichacha shows that the company is fully owned by Xintai.